Rochester, NY 6/15/2009 11:49:37 PM
Early Afternoon Gainers AMEX - CSCO,JAZZ,ORCL - Sourced WhisperFromWallStreet.com
Cisco Systems, Inc. - Jazz Pharmaceuticals, Inc. - Oracle Corporation
Early Afternoon Gainers AMEX - CSCO,JAZZ,ORCL - Sourced WhisperFromWallStreet.com
WhisperfromWallStreet.com is an award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, and teaching you how to become a better trader. We can now even deliver this information instantly to our "Penny Stock Alert" gadget that sits right on your Microsoft Vista or iGoogle desktop. You will know from the instant you get your confirmation email that we are different. What do you have to lose except a little time and a chance to really learn how to make money trading.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
Cisco Systems, Inc.,CSCO
19.21 Down 0.70 (3.52%) 12:38PM ET
Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP)-based networking and other products relating to the communications and information technology industry worldwide. The company offers routers that interconnect IP networks and moving information between networks; switching systems, which provide connectivity to end users, workstations, and servers; application networking solutions; home networking products, such as voice and data modems, network cards, media adapters, Internet video cameras, network storage, and USB adapters; and Cisco security solutions to protect information systems.
Last Trade: 19.14
Day's Range: 19.11 - 19.70
52wk Range: 13.61 - 26.70
Volume: 22,863,537
---
Jazz Pharmaceuticals, Inc.,JAZZ
4.43 Up 1.79 (67.80%) 12:39pm ET
Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The company's marketed products include Xyrem for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy; and Luvox CR for obsessive compulsive disorder and social anxiety disorder. Its product candidate in Phase III clinical trials comprise JZP-6 for the treatment of fibromyalgia.
Last Trade: 4.33
Day's Range: 3.38 - 4.75
52wk Range: 0.52 - 8.95
Volume: 16,134,808
---
Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
---
Oracle Corporation,ORCL
20.14 Down 0.71 (3.41%) 12:41pm ET
Oracle Corporation, an enterprise software company, engages in the development, manufacture, distribution, servicing, and marketing of database, middleware, and application software worldwide. The company's New Software Licenses segment provides licenses for database and middleware software, including database management software, application server software, business intelligence software, identification and access management software, analytics software, content management software, development tools, and data integration software; and applications software that offers enterprise information for customer relationship management, financials, insurance, human resources, maintenance management...
Last Trade: 20.06
Day's Range: 20.03 - 20.65
52wk Range: 13.80 - 23.62
Volume: 15,497,527
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
